本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Acrivon Therapeutics, Inc.

1.48
+0.03502.43%
成交量:48.52萬
成交額:71.36萬
市值:4,624.34萬
市盈率:-0.62
高:1.54
開:1.43
低:1.42
收:1.44
資料載入中...
2024/04/11

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/04/09

重要事件披露

Form 8-K - Current report
2024/03/29

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/28

重要事件披露

Form 8-K - Current report
2024/03/28

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/04

重要事件披露

Form 8-K - Current report
2024/02/15

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/15

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/08

重要事件披露

Form 8-K - Current report
2024/01/08

重要事件披露

Form 8-K - Current report
2023/12/13

SEC問詢函

Form CORRESP - Correspondence
2023/12/08

重要事件披露

Form 8-K - Current report
2023/11/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/09

重要事件披露

Form 8-K - Current report
2023/09/06

重要事件披露

Form 8-K - Current report
2023/08/11

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/08/11

重要事件披露

Form 8-K - Current report
2023/08/11

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]